IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BVF Inc

Q1 2019 Holdings

Filed 2019-05-15 | 53 holdings | $98.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Cytomx Therapeutics Inc(CTMX)COM23284F105$12.9M1,198,00013.1%
Cytokinetics Inc(CYTK)COM NEW23282W605$30.8M3,801,81731.4%
Arcus Biosciences Inc(RCUS)COM03969F109$35.1M2,810,22335.8%
PreviousPage 2 of 2